Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Pharmacy update: DEA approval pending, initial inventory staged; staff recommends gap malpractice coverage
Summary
Staff reported that the clinic’s DEA approval is in final review at headquarters and that the pharmacy has initial inventory and systems ready to begin filling prescriptions for clinic patients once the DEA number and NPI are issued. Staff also discussed gap malpractice insurance and telepharmacy training.
Clinic staff told the Dahl Memorial Clinic Planning Committee on Jan. 21 that the clinic’s DEA approval for the pharmacy is in the final stages at headquarters and the clinic expects the DEA notice soon. Once the DEA number is issued staff will apply for an NPI and begin limited prescription fills for clinic patients.
Staff said…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat